Riesling Base Metal Project pxrf Soil Geochemistry

Similar documents
First Results Prospector Drilling Program

January A different kind of Zinc Explorer

Mutiny continues to hit high grade gold and copper intersections in latest Deflector drilling

XanADu: A Phase II trial of Xanamem TM in mild Alzheimer's disease

For personal use only

Investor Presentation

Investor presentation. Bioshares Biotech Summit July 2017

Kihabe Zn, Pb, Ag Project Botswana

For personal use only

World leader in navigated, non-invasive brain stimulation therapy and diagnosis

Disclaimer. Matrix Metals Limited Presentation October

Developing Xanamem for Alzheimer s Dementia

For personal use only

TRI ORIGIN MINERALS LTD

ASX/Media Announcement 24 December 2010

Investment in MGC Pharmaceuticals

28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report

CASE STUDIES USING PORTABLE XRF ANALYSERS DURING SOIL CONTAMINATION AND MINERAL EXPLORATION PROJECTS. Todd Houlahan 21 st IGES, Dublin, Ireland, 2003

NOXOPHARM CORPORATE PRESENTATION FNN SHAW&PARTNERS INVESTOR EVENT ASX: NOX

SCOUT DRILLING COMPLETED ON KELLERBERRIN URANIUM PROJECT

DMX-200 for Diabetic Kidney Disease

For personal use only

Important Notices. BASIS CPD Points PN/50971/1516/g

PATENCY-1 Top-Line Results

PXL770, a novel direct AMPK activator, improves metabolic disorders in a diet-induced mice model of obesity and diabetes

Star Zinc Project Update Released 07:00 15-Oct-2018

Ayawilca Zinc Project Peru: Targeting Resource Growth in 2017

Transforming IVF and Biological Separations Presentation by Executive Chairman, Alison Coutts

PRELIMINARY DRILLING RESULTS FROM FIVE NEW DRILL HOLES EXTEND IRON MINERALISATION AT MARIELA

Tamsulosin Hydrochloride 0.4 mg Capsule

For personal use only

BISIE PROJECT UPDATE

NOXOPHARM POSTS CORPORATE PRESENTATION AHEAD OF CONFERENCE ASX: NOX. Presentation at Singapore Investor Conference Review of first year of operation

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

RULES OF CONDUCT OF INSIDERS RESPECTING

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update

THE VILLAGE AT SAVANNAH QUARTERS

Novo Nordisk has proposed to acquire Ablynx for up to per share in cash, consisting of upfront and 2.50 in Contingent Value Rights

For personal use only

Korean Airlines Q Results

Employment Contract. This sample employment contract is from Self-Employment vs. Employment Status, CDHA (no date available)

Mental Toronto Hydro

For personal use only

Palmer Deposit 2018 Resource* INDICATED 5.2% Zn, 1.5% Cu, 30.8 g/t Ag, 0.3 g/t Au INFERRED 5.2% Zn, 1.0% Cu, 29.2 g/t Ag, 0.

USPSTF Draft Recommendations Investor Call. October 6, 2015

PROACTIVE INVESTOR PRESENTATION

Advancing Pancreatic & Liver Cancer Treatment

This is a licensed product of Ken Research and should not be copied

Advancing New Treatments for DMD and C. difficile Infection

Macmillan Pass Zinc Project: Growing an Already World-Class Asset

ASX/Media Announcement

Delivering high quality, cost effective cannabinoid medicines to patients (ASX:AC8) September 2018

Environmental, Health and Safety

Q4 Report Webcast February 7, 2019 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO

EKOS. Interventional Vascular 3 February, Imagine where we can go.

Please complete the medical history section below so that we can be sure to respond to any

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

January 30, 2018 Dow Wilson President and Chief Executive Officer

PRESENTATION ON 2017 THIRD QUARTERLY RESULTS

which has been used to help the treatment of epilepsy, seizures, alleviate neuropathic pain and muscular dystrophy.

Improving the lives of people with neurological conditions. Annual General Meeting Neurotech International Limited (ASX: NTI) November 2017

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Shareholder Presentation Annual Meeting 2018

Accelerated Mining and Gold Production Completion of Strategic Alliance with Territory Resources for Tennant Creek $2m Placement at 56.

Not an Offer for Securities

For personal use only

Michael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation

Autism Housing Pathways: Building Roads to Home. Autism Update 2010 Conference April 8, 2010

Phylogica 2016 Broker Meets Biotech (PYC:ASX) Developing new drugs against intracellular cancer targets beyond the reach of existing therapies

Cavosonstat Phase 2 Trial Results. November 28 th, 2016

Prediction of Selenium Leaching. Stephen Day and Kelly Sexsmith SRK Consulting

FORM8-K HILLENBRAND,INC.

Designing a Smoke-Free Future

Expanding Resources in the Caribbean

Chinese Zinc Sulfate Monohydrate testing. Dick Camp Kronos Micronutrients

Soil Conditions Favoring Micronutrient Deficiencies and Responses in 2001

Shea Clark Smith / MEG, Inc., P.O. Box 18325, Reno, Nevada, USA Tel:

Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook ( )

TSX: LUN OMX: LUMI Corpora Corpor t a e t Presen esen a t tion

Global Dravet Syndrome Market: Industry Analysis & Outlook ( )

Product Stewardship Information Sheet CH350LN

Slide 1. Investor presentation. London 5 February 2019

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

DR.NEIL FRAZER CHIEF EXECUTIVE OFFICER & MANAGING 1

APPLICATION INSTRUCTIONS

New Ideas. Better Medicines. Third Quarter Financial Results Conference Call

*To reserve your place in the training, you must submit the completed application along with a minimum

Living Immunotherapies. Corporate Presentation OCTOBER 2018

Limitations to Plant Analysis. John Peters & Carrie Laboski Department of Soil Science University of Wisconsin-Madison

Product Stewardship Information Sheet CH200LN-02

PRESENTATION. AGM 27 th OCTOBER 2015 ASX: PAA ACN

Constitution for the National Association to Advance Fat Acceptance, Inc. PREAMBLE

CytoDyn Announces Initiation of Metastatic Triple Negative Breast Cancer Trial and Reiterates Phase 3 Goal in Cancer

TSX Venture: RVV OTCQB: RVVTF

Linear sweep voltammetry as a technique to characterize mining wastes

Transcription:

pxrf Soil Geochemistry Ken Harvey Non-executive Director Superior Resources Limited Riesling Located 280km NW Townsville & 17km SSW of Mount Surprise, North Queensland VMS (or Broken Hill) type deposit - (6km of Gahnite Quartzite ) 3000ppm Zn soil anom ± Cu, Ag, Pb, Bi & magnetic anomaly at Central Riesling AIG pxrf Seminar November 2015

Information Purposes: This presentation is for information purposes only. The information contained in this presentation does not constitute an offer, invitation, solicitation or recommendation in relation to the purchase or sale of shares in Superior Resources Limited (Superior) in any jurisdiction. The information in this presentation is provided in summary form, has not been independently verified, and should not be considered to be comprehensive or complete. Not Financial Product Advice: This presentation does not constitute financial product or investment advice. It has been prepared without taking into account the objectives, financial circumstances or needs of recipients and cannot be relied upon as advice to recipients. Before making an investment decision, investors or prospective investors should consider the appropriateness of the information having regard to their own objectives, financial situation and needs and seek legal and taxation advice appropriate to their jurisdiction. Forward Looking Statements: This presentation may contain forward looking statements. Forward looking statements are often, but not always, identified by the use of words such as seek, indicate, target, anticipate, forecast, believe, plan, estimate, expect and intend and statements that an event or result may, will, should, could or might occur or be achieved and other similar expressions. Indications of, and interpretations on, future expected exploration results or technical outcomes, production, earnings, financial position and performance are also forward looking statements. The forward looking statements in this presentation are based on current interpretations, expectations, estimates, assumptions, forecasts and projections about Superior, Superior s projects and assets and the industry in which it operates as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made. The forward looking statements are subject to technical, business, economic, competitive, political and social uncertainties and contingencies and may involve known and unknown risks and uncertainties. The forward looking statements may prove to be incorrect. Many known and unknown factors could cause actual events or results to differ materially from the estimated or anticipated events or results expressed or implied by any forward looking statements. All forward-looking statements made in this presentation are qualified by the foregoing cautionary statements. Disclaimer: Superior and its related bodies corporate, any of their directors, officers, employees, agents or contractors do not make any representation or warranty (either express or implied) as to the accuracy, correctness, completeness, adequacy, reliability or likelihood of fulfilment of any forward looking statement, or any events or results expressed or implied in any forward looking statement, except to the extent required by law. Superior and its related bodies corporate and each of their respective directors, officers, employees, agents and contractors disclaims, to the maximum extent permitted by law, all liability and responsibility for any direct or indirect loss or damage which may be suffered by any person (including because of fault or negligence or otherwise) through use or reliance on anything contained in or omitted from this presentation. Other than as required by law and the ASX Listing Rules, Superior disclaims any duty to update forward looking statements to reflect new developments. The information in this presentation that relates to exploration results is based on information compiled by Mr Ken Harvey, a director and shareholder ofthe Company, who is a Member of the Australasian Institute of Mining and Metallurgy and a Member of the Australian Institute of Geoscientists. Mr Harvey has sufficient experience which is relevant to the style of mineralisation and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the 2012 Edition of the Australasian Code for Reporting of Exploration Results, Mineral Resources and Ore Reserves. Mr Harvey consents to the inclusion in this presentation of the matters based on his information in the form and context in which it appears. Limitations & JORC

Prospect Summary Cooktown Ironwood (Erythrophleum chlorostachys) Gahnite Zinc Spinel - ZnAl 2 O 4 Occurrence - usually green octahedral crystals Balcooma Octahedral Gahnites

ICP Data pxrf Data pxrf Data pxrf Data Regional Zinc Soil Geochemistry on Google Earth Riesling Zinc Soil Geochemistry pxrf Data

Cooktown Ironwood trees show as pale red anomalies on Aster 3,2,1 (RGB) Images 500ppm zinc soil anomalies indicated by white lines Very good agreement indicates that the Ironwood trees either like zinc in soils or prefer alteration zones or both Note: Erythrophleum chlorostachys (Cooktown Ironwood) is poisonous to stock and probably humans Aster 3,2,1 (RGB) Image and 500ppm Soil Zinc

Cooktown Ironwood Trees on Alteration Zone Complex Folding of Siliceous Band in Alteration Gahnite Gahnite Quartzite Horizon Gahnite (ZnAl 2 O 4 ) Quartzite

Geobotanical Anomaly on Mineralisation Geobotanical Anomaly on Mineralisation High Grade Lead Gossan High Grade Lead (29% Pb, 44g/t Ag, 0.4% Zn, 0.3% Cu)

Riesling Central Gossan Riesling Central Gossan (0.4% Zn, 0.4% Cu)

Soil Geochemistry pxrf (Total) vs ICP (ME ICP41 Acid Soluble) Adjacent Gossan Soil Samples 10-20cm Depth -80# Sieved Samples This Sample: 17061 Zn, 837 Cu, 3021 Pb (pxrf) 1990 Zn, 705 Cu, 1890 Pb (ICP)

Zinc (pxrf) Zinc (ICP) Similar Anomaly Pattern Ratio XRF/ICP: 0.98 to 8.57

Copper (pxrf) Copper (ICP) Similar Anomaly Pattern Ratio XRF/ICP: 0.33 to 3.50

Lead (pxrf) Lead (ICP) Similar Anomaly Pattern Ratio XRF/ICP: 0.33 to 3.50

Iron (pxrf) Iron (ICP) Similar Anomaly Pattern Ratio XRF/ICP: 1.12 to 3.10

Molybdenum (pxrf) Molybdenum (ICP) Similar Anomaly Pattern Ratio XRF/ICP: 0.00 to 3.00

Sulphur (ICP Image & pxrf Contours) Similar Anomaly Pattern

Bismuth (ICP) Silver (ICP) Good ICP Anomalies Don t use pxrf at these levels

Zinc (pxrf/icp) Zinc (ICP/pXRF)

Zinc (ICP/pXRF) + Fe Contours Zinc (ICP/pXRF) + Bi Contours (ICP) (ICP)

Mag (RTP) + Cu Contours Mag (RTP) + Fe Contours (ICP) (ICP)

Conclusions Terra Search Bench Top XRF

Niton Portable XRF Analyser vs ME-ICP41 (ALS) pxrf cheaper and more immediate but needs to be setup properly and with standards (eg. Terra Search) Similar anomaly patterns from pxrf and ICP analyses for Cu, Pb, Zn, Fe, Mo & S Apparently better results from ICP for low-level elements Ag & Bi pxrf/icp Zn (Total/Soluble Zn) ratio may be useful for determining the centre of mineralising system for metamorphosed stratiform/vms deposits Either: 1. Zinc doesn t compete well for sulphur during metamorphism and forms gahnite (also goes into staurolite) or 2. Acid from oxidation of massive sulphides leaches soluble zinc from the weathered zone (cf. Balcooma)

Deposit Model Syngenetic/Stratiform/VMS Massive Sulphide Metamorphosed Deformed and Remobilised Extensional Trough Setting?

Atlantis II Deep in the Red Sea after Thisse, Guennoc, Pouit and Nawab Episodes, 1983, No.3

Was the Riesling mineralisation deposited within a Deep structurally similar to the Atlantis II Deep in the Red Sea?